text:
We sell Portable yet Permanent steel shelters, Carports and Buildings for businesses and residents residing in Kenmore. Our structures will give you many years of maintenance free service and lasting protection from the elements.
We now offer an optional 6/12 roof pitch with vertical roofing that is ideal for higher elevations and snow areas.
With standard sizes up to 30' wide and custom sizes well beyond 30' wide and as long as you like, we can cover just about anything.
We offer two roof designs for our customers that live in Kenmore, the Standard Roof with round corners, no eaves and horizontal roofing. Roof ribs run lengthwise front to back. The A-Frame with eaves and vertical roofing is our best and strongest roof.
Design to fit your needs, whether fully enclosed with windows and doors, or partially enclosed or open. It's up to you. You tell us what you want and it will be built to fit your needs.
RV's - Cars - Boats - Animals and more in Kenmore. We Have You Covered. If you live in Kenmore Delivery and Installation is all included in the price.
-PRICE- We will meet or beat any of our competitors' prices. Our service, however, can't be beat. We are an accredited member of the Better Business Bureau with an A+ Rating and customer service comes first.
-PAYMENT, A small payment by credit card will be due when you place your order.
Our website is for browsing at our pictures to give you more ideas. We do business the old fashioned way, we like to talk with you in person or on the phone at which time we will give you a price based on your needs and it only takes a couple of minutes.
Call me personally with any questions you may have, I look forward to talking with you about your needs..
Office: (253) 549-4186
Cell: (360) 731-3452
Email: email@example.com
The Perfect Solution For
RVs | Cars | Animals | and More!
Tacoma, Washington
Most Buildings Built In A Day
Lasts a Lifetime
Prices Start Under $1,000
Installation is Included!
We Build Custom Sizes To Fit Your Needs


text:
Pirelli Scorpion Winter (Pncs) Tyres Available in Totnes
Scorpion Winter (Pncs)
SCORPION™ WINTER has been designed to fit modern SUVs and CUVs, with a special focus on the high-end segment. The goal is no fear in down-hill braking and cornering in winter road conditions, whilst maintaining total control.
- Directional & symmetric tread pattern design with modular block geometry and sipe layout
- Circumferential grooves: two and four groove version
- New mould profile
- New tread pattern compound with innovative materials
- Increasing "grip": handling and traction on snow conditions and braking performance on dry surfaces
- Improves the water expulsion
- Provides an optimized footprint area
- Maximum grip both on snow and wet road conditions, weight reduction
- Improved handling on snow surfaces and reduce the braking distance in all winter driving conditions. Improve traction, lateral force during cornering, slalom and lane change situations
- Excellent wet handling and wet braking performance
- Progressive and responsive handling in dry conditions
- Lower fuel consumptions and maximum grip both on snow and wet road conditions
Sorry, we currently do not have any tyres with the Scorpion Winter (Pncs) pattern in stock.
Contact us to see if we can order these in for you.

subset: commoncrawl


text:
PI3K-Akt signaling pathway
The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The binding of growth factors to their receptor tyrosine kinase (RTK) or G protein-coupled receptors (GPCR) stimulates class Ia and Ib PI3K isoforms, respectively. PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) at the cell membrane. PIP3 in turn serves as a second messenger that helps to activate Akt. Once active, Akt can control key cellular processes by phosphorylating substrates involved in apoptosis, protein synthesis, metabolism, and cell cycle.


text:
Here are the point values for each letter in socs for the two most popular word scramble games - Scrabble and Words With Friends.
These are the values for each letter/tile in Scrabble and Scrabble Go. The letters socs combine for a total of 6 points (not including bonus squares).
These are the values for each letter/tile for socs in Words With Friends and Words With Friends 2. These letters are worth a total of 7 points (not including bonus squares)
Now that you have successfully unscrambled SOCS, what now? Simple, Our Word Unscrambler found 26 playable words ready to be used in several word games!
All of the words that you unscrambled using the letters socs can be used in Scrabble, Scrabble Go and Words With Friends!
socs unscrambles into many words! Here is the definition of one of those unscrambled words.


text:
No products
Check out
Display all pictures
Brand: Kishigo
Style: RTCID
Condition: New
Note: Return of this item is subject to a 20% or $25 (whichever is greater) restocking charge, in addition to both outbound and return freight costs.
More details
Tweet Share Google+ Pinterest
0 Item Items
Out of Stock
Warning: Last items in stock!
Availability date:
The minimum purchase order quantity for the product is 1
Add to cart
No customer reviews for the moment.
Kishigo RTCID Retractable Clear ID Pocket


text:
BBS CHR Nurburgring Edition 19x9.5, 5x112, ET45
- Description
- Fitment
Supreme Power Is The Premier BBS Street & Motorsport Dealer.We are the highest volume independent BBS warehouse distributor. We offer sales, repair, rebuilding, and refinishing services to handle all your BBS wheel needs.
If you are looking for the absolute fastest shipping times, soonest availability, and the best price on any BBS wheels, place your order in confidence through Supreme Power.
Have a question?
To SupremePower part specialists it is important to us that you choose the correct product, size, fitting, part or accessory for your vehicle. One of our support specialists are on standby to answer any questions that you may have.
EMAIL: email@example.com
We are located in Southern California: 1562 Kimberly Ave, Fullerton, CA. 92831
Share this product
Have a Question? Ask a Specialist
SupremePower: Shop with confidence. Experience personalized recommendations from our unbiased experts combined with our unmatchable customer service. If you have any questions regarding any of our products, please ask one of our specialists on +1.(714).632.1951 or email email@example.com
Magnuson-Moss Warranty Act
Legally, a vehicle manufacturer cannot void the warranty on a vehicle due to an aftermarket part unless they can prove that the aftermarket part caused or contributed to the failure in the vehicle (per the Magnuson Moss Warranty Act (15 U.S.C. 2302(C)) Learn more...


text:
The State Hermitage museum decorations – photo 98
Posted on February 10, 2013
You are free to copy and distribute PickDecor content for noncommercial purposes as long as a backlink to FlatProject are provided.
All trademarks are the property of their respective owners.
PickDecor publishes content only under Creative Commons Attribution License. Published content was obtained from public sources or posted by users.
If you are the copyright holder and find inappropriate the placement of your content on our website, we are ready to remove them on the first request.


text:
Outlaw From Hell Vintage Metal Sign
From the Steve McDonald licensed collection, this Outlaw From Hell vintage metal sign measures 12 inches by 18 inches and weighs in at 2 lb(s). This vintage metal sign is hand made in the USA using heavy gauge american steel and a process known as sublimation, where the image is baked into a powder coating for a durable and long lasting finish. It then undergoes a vintaging process by hand to give it an aged look and feel. This vintage metal sign is drilled and riveted for easy hanging.


text:
Misha Friedman began training his lens on tuberculosis patients in the former Soviet Union in 2007, when he worked in logistics for the nonprofit Doctors Without Borders.
At first he took photos in his spare time, whiling away his off days by documenting the patients and hospital workers he met on the job. But this hobby quickly turned into more than that when he won a photo competition judged by renowned photojournalist Gary Knight, founder of the VII photo agency.
"He awarded me a grant and a prize," Friedman recalls. "I was on the sidelines at that point, contemplating whether I should convert this hobby into a career. It was one of the few moments when I thought that I should pursue this after all."
Friedman got down to work. He's been crafting intimate, behind-the-scenes photos of the ravages of this slow-moving disease ever since. For his series from the former Soviet Union, Friedman's photo essays are deliberately focused on themes. He identified specific emotions and ideas for each of the countries where he traveled — Uzbekistan, Russia and Ukraine.
Stigma became his focus in Uzbekistan. In one photo, a man with his head cropped out of frame wears a dress shirt that looks to be two sizes too big on his withered frame. Another photo simply shows the contours of a patient's emaciated body. His ribs and spine look like they are carved into his back, casting dark shadows.
In Russia, Friedman documented how patients received treatment according to social class. Those who received the worst treatment were the poor, homeless and handicapped. One photo shows an empty wheelchair and three patients forced to stay in a hallway because of overcrowding. Urine is spilled at the foot of one of the patients. "The closer to death, the worse you were treated," explained Friedman.
An overarching theme of Friedman's coverage is how the lack of funding since the fall of the Soviet Union has affected treatment. Photos show peeling paint in the office of a Russian hospital, rooms with filthy mattresses, and solitary patients crouched in their rooms. Friedman revisited this same hospital summer and found that, sadly, nothing has changed.
But amid the obvious suffering, Friedman has also tried to look for signs of optimism. His favorite photograph from his series is of one such moment. In the photo, a nurse peers at a scale to check the weight of a patient, a key indicator of how a patient is faring against the disease. "It was a rare moment of true empathy," he says.
See more of Misha Friedman's work at his website.
Copyright 2021 NPR. To see more, visit https://www.npr.org.


text:
If the .H1F file is known to your system, it is possible to open it by double clicking the mouse or pressing ENTER. This operation will start applications associated with the .H1F file installed on your system. If the system encounters a file for the first time and there are no relevant associations, the action will end with a system's proposal to find the appropriate software on your computer or in the Internet.
Sometimes it happens that the files of the .H1F type a wrong program is assigned. This can sometimes be the result of the action of hostile programs such as viruses and malware, but most often it is the result of an incorrect association of an application with the .H1F file extension. If, during the operation of a new type of .H1F files, we will indicate to the system a wrong program, the system will erroneously suggest its use every time it encounters this type of file. In this case, try to re-select the appropriate application. Right-click on the .H1F file, and then select from the menu the option "Open With ..."
and "Choose default program"
. Now select one of the installed application from the list above and try again.
If our system cannot cope with the .H1F extension and all the automatic and semi-automatic methods to teach it have failed, we can only manually edit the Windows registry. This register stores all information about the operation of your operating system, including file extension associations with programs to support them. The REGEDIT entered in the window "search for programs and files" or "run" for older versions of the operating system, gives the access to the registry of the operating system. All operations performed in the registry (even those little complicated for the .H1F file extension) have a significant impact on the operation of our system, therefore, before any modifications, make sure that you have a copy of the current registry. The section important for us is the key HKEY_CLASSES_ROOT . This manual shows step by step how to modify the registry, specifically the entry in the registry that contains information about .H1F file.
"search for programs and files"
(in older versions of Windows this is called "Run"
), type the command "regedit"
and then confirm the operation by pressing "ENTER". This operation will start the system registry editor. This tool allows you to not only view the existing entries, but also to modify, add or delete them manually. Due to the fact that the Windows registry is essential to its operation, all operations performed on it should be done carefully and deliberately. Reckless removal or modification of the wrong key can permanently damage the operating system. ctr + F
or the Edit menu and by selecting "Find"
look for the .H1F extension you are interested in by typing it in the search window. Confirm by clicking OK or by using the ENTER key.


text:
wax thread
Size in cm Necklace length: 78 cm (max)
Pendant length : 19 cm
Size in inches Necklace: length 30,7 in
Pendant length : 7,5 in
Love & happiness
We cooperate with Deutsche Post- DHL Global Mail, a cost effective and one of the most reliable shipping companies for international orders.
Usually, the shipping time for EU countries is 4-7 working days,
USA & Canada 5-9 working days,
Rest of the world 7-14 working days.
Awatara offers Free International Express Shipping (by DHL Express) for all orders over 150 €.
DHL Express Shipping time for EU countries is 2-3 working days,
USA & Canada 3-5 working days
Rest of the world is about 5-7 working days.
However, If you wish express delivery anyway (even for lower cost orders), you may choose DHL express option at the shipping section (Payment procedure), paying an additional charge.
For domestic shipping we cooperate with ACS and shipping time is 1-2 working days.


text:
Questions per page
For longer quizzes it makes sense to stretch the quiz over several pages by limiting the number of questions per page. When adding questions to the quiz page breaks will automatically be inserted according to the setting you choose here. However you will also be able to move page breaks around by hand later on the editing page.


text:
Charcoal Damask
- Fabric: 100% cotton, medium weight fabric
- Print: Charcoal and tan
- Construction: All my covers have the same printed fabric front and back and have a deep envelope enclosure which is triple-stitched for durability. All made in my smoke and pet-free studio.
- Size: Choose the size which corresponds to your pillow form size. I will then ensure that your cover provides a snug, professional fit for your pillow form size. I generally make the covers about 1" smaller than your pillow form size. If you have additional sizing questions, see my "sizing" information or contact me directly at email@example.com
We Also Recommend


text:
National Institute of Mental Health (NIMH)
See Notices of Special Interest associated with this funding opportunity
August 14, 2019
February 10, 2020
March 10, 2020, March 10, 2021, March 10, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
June 2020, June 2021, June 2022
December 2020, December 2021, December 2022
Not Applicable
It is critical that applicants follow the instructions in the Research (R) Instructions in the SF424 (R&R) Application Guide,except where instructed to do otherwise (in this FOA or in a Notice from NIH Guide for Grants and Contracts ).
Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions.
Applications that do not comply with these instructions may be delayed or not accepted for review.
Despite the rapid growth and adoption of machine learning and artificial intelligence (AI) techniques to scientific questions, the lack of insight into the inner workings of these approaches has impeded full scientific understanding. For NIMH, the ultimate goal is a deep mechanistic understanding of normative brain functions and the pathophysiology of psychiatric disorders. However, machine learning techniques have often been applied to categorize and predict neural and behavioral outcomes without providing an understanding of what drives those predictions and classifications. Without knowing the factors critical to a machine-learning based outcome, it is difficult to optimize these approaches for novel conditions or to identify targets for further study or intervention development.
eXplainable Artificial Intelligence (XAI) consists of artificial intelligence algorithms in which the processes of arriving at final actions (e.g., predictions, classifications, and recommendations) can be easily understood by its users. XAI aims to overcome limitations of classical machine learning, including a lack of transparency and non-generalizability. In optimizing computations to maximize accuracy or performance, a standard AI may learn useful rules from the specific training set. However, it may also learn inappropriate or non-generalizable rules. XAI provides methods to examine existing machine learning models more closely and new approaches that are explicitly designed to provide greater transparency. In an open and transparent XAI, users should have the ability to audit rules to discover how likely it is that the system will generalize outside a specific training-set to future real-world data.
NIMH is interested in transforming classical black box machine learning models into XAI glass box models, without significantly sacrificing performance. The goal of this FOA is to encourage investigators to apply XAI techniques to further our understanding of the neural circuitry linked to behavior and to improve our understanding of therapeutic strategies to enhance cognitive, affective, or social function. To develop new treatments for mental illness, a better understanding of how to modulate neural dynamics responsible for complex functional domains and/or maladaptive behaviors is critical. In order to achieve this understanding using XAI techniques, collaborations between computational and experimental investigators are strongly encouraged. In the context of mental health, the amount and type of explanatory information accessed may vary based on the stakeholder (clinicians, patients, or researchers) interacting with the AI system.
Projects developing XAI for use in animal and/or human research are appropriate to this announcement. Human studies may involve healthy controls, community samples, and/or patient populations.
Studies proposed under this FOA must:
Examples of XAI research projects of interest to NIMH include, but are not limited to, the following:
Neurobehavioral modulation performed by:
Designing XAI models with the sole purpose of explanation
Rich labeling of a model's features with semantic information that is understandable by the users (label propagation techniques are encouraged)
Estimating the influence of a given feature on model prediction accuracy or deep neural network decisions by using causal statistical methods
Integrating data-driven and theory-driven models (e.g., machine learning models and biophysically informed models)
Implementing biologically inspired machine learning techniques that use the anatomy or physiology of the nervous system to constrain or optimize their implementation
Allowing a machine learning algorithm to unbiasedly discover the governing equations underlying a dynamical system by analyzing co-varying multimodal (or parametric) data
Using XAI algorithms to understand biological mechanisms of action and/or complex changes in brain network dynamics mediated by small molecule drugs, promising biologics, behavioral interventions, environmental manipulations, or developmental changes
Expert-in-the-loop machine learning, combining expert knowledge and machine intelligence to create more effective machine learning algorithms. Humans could be involved in both the training and testing stages of building an algorithm.
XAI algorithms applied to rigorous clinical studies such as biological and/or behavioral marker-guided adaptive trial designs, to efficiently and quickly mine complex datasets to reveal optimal treatment approaches based on machine-explained predictive markers as well as patient bio-types linked to treatment response.
XAI application in the early phases of treatment development to integrate data across species and levels of analyses (i.e., omics, anatomy, physiology, and functional effects) to 1) identify and mechanistically explain potential treatment targets that are amendable to evaluation in animals and/or 2) suggest optimal neurophysiological and behavioral readouts in animals that are predictive of effects in humans.
XAI frameworks able to identify the parts in the brain-behavioral signal (images, videos, audio, or physiological time series) most responsible for the unbiased classifications/predictions by conducting explicit and interpretable signal perturbations.
In convolutional neural network "visual explanations" can be produced by applying Gradient-weighted Class Activation Mapping and using the gradients of the target concepts, flowing in the final convolutional layer to produce coarse localization maps highlighting the important regions in the image for predictions.
XAI algorithms substituting classical Back-Propagation learning with layer-wise, kernelizing deep learning architectures. Reproducing Kernel Hilbert Space to increase the specificity of the targets at each layer and preserve the perceptual distance across clusters during training, bringing explainability to kernelize deep learning architectures.
XAI algorithms using post-training rule-extraction. Once the parameters are trained, mapping the input features into neural network the dynamics and predictions to add, for add explanatory value to the predictions .
Areas of Low Program Priority
Mathematical or computational research on AI not directly related to neural systems
Solely behavioral research not involving measurement or manipulation of neural circuits
Applications submitted under this FOA are required to include an active manipulation of a biological process in humans, animals, or both. For studies involving humans, active manipulation of a biological process may meet the NIH definition of a clinical trial. For these reasons, only mechanistic clinical trials will be accepted under this FOA. NIH defines mechanistic clinical trials as studies designed to understand a biological or behavioral process, the pathophysiology of a disease, or the mechanism of action of an intervention (see NOT- MH-19-006 ); In contrast, applications proposing studies that evaluate safety, clinical efficacy, clinical effectiveness, management, and/or implementation of an intervention are not allowable under this FOA and will not be reviewed. Instead, these types of studies should be submitted to one of the NIMH FOAs that support clinical trials evaluating safety, clinical efficacy, clinical effectiveness, management and/or implementation. For more information, please refer to the NIMH Clinical Trials Funding Opportunity Announcements webpage.
Applicants are strongly encouraged to consult with Scientific/Research Contacts when developing plans for an application. Early contact will provide an opportunity to clarify NIMH priorities and guidelines as well as to discuss specific components of the application subject to peer review.
Grant: A support mechanism providing money, property, or both to an eligible entity to carry out an approved project or activity.
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types. Only those application types listed here are allowed for this FOA.
Need help determining whether you are doing a clinical trial?
The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Higher Education Institutions
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Applicant organizations
Applicant organizations must complete and maintain the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. All registrations must be completed prior to the application being submitted. Registration can take 6 weeks or more, so applicants should begin the registration process as soon as possible. The NIH Policy on Late Submission of Grant Applications states that failure to complete registrations in advance of a due date is not a valid reason for a late submission.
Program Directors/Principal Investigators (PD(s)/PI(s))
All PD(s)/PI(s) must have an eRA Commons account. PD(s)/PI(s) should work with their organizational officials to either create a new account or to affiliate their existing account with the applicant organization in eRA Commons. If the PD/PI is also the organizational Signing Official, they must have two distinct eRA Commons accounts, one for each role. Obtaining an eRA Commons account can take up to 2 weeks.
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF424 (R&R) Application Guide.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
The NIH will not accept duplicate or highly overlapping applications under review at the same time. This means that the NIH will not accept:
The application forms package specific to this opportunity must be accessed through ASSIST, Grants.gov Workspace or an institutional system-to-system solution. Links to apply using ASSIST or Grants.gov Workspace are available in Part 1 of this FOA. See your administrative office for instructions if you plan to use an institutional system-to-system solution.
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
The letter of intent should be sent to:
Email: firstname.lastname@example.com
Additional PD/PIs, key personnel, and collaborators should provide appropriate breadth and balance of applied machine learning - data-driven modeling - expertise and neuroscience research expertise and complementary abilities organized around a scientific framework to address fundamental question(s) in neuroscience or psychiatric research.
All instructions in the SF424 (R&R) Application Guide must be followed.
Research Strategy
In addition, all applications under this FOA are also expected to include one of the following:
The following modifications also apply:
If you answered Yes to the question Are Human Subjects Involved? on the R&R Other Project Information form, you must include at least one human subjects study record using the Study Record: PHS Human Subjects and Clinical Trials Information form or Delayed Onset Study record.
Study Record: PHS Human Subjects and Clinical Trials Information
All instructions in the SF424 (R&R) Application Guide must be followed.
Note: Delayed onset does NOT apply to a study that can be described but will not start immediately (i.e., delayed start).All instructions in the SF424 (R&R) Application Guide must be followed.
Foreign (non-U.S.) institutions must follow policies described in the NIH Grants Policy Statement, and procedures for foreign institutions described throughout the SF424 (R&R) Application Guide.
See Part 1. Section III.1 for information regarding the requirement for obtaining a unique entity identifier and for completing and maintaining active registrations in System for Award Management (SAM), NATO Commercial and Government Entity (NCAGE) Code (if applicable), eRA Commons, and Grants.gov
Part I. Overview Information contains information about Key Dates and times. Applicants are encouraged to submit applications before the due date to ensure they have time to make any application corrections that might be necessary for successful submission. When a submission date falls on a weekend or Federal holiday , the application deadline is automatically extended to the next business day.
Organizations must submit applications to Grants.gov (the online portal to find and apply for grants across all Federal agencies). Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH's electronic system for grants administration. NIH and Grants.gov systems check the application against many of the application instructions upon submission. Errors must be corrected and a changed/corrected application must be submitted to Grants.gov on or before the application due date and time. If a Changed/Corrected application is submitted after the deadline, the application will be considered late. Applications that miss the due date and time are subjected to the NIH Policy on Late Application Submission.
Applicants are responsible for viewing their application before the due date in the eRA Commons to ensure accurate and successful submission.
Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement .
Pre-award costs are allowable only as described in the NIH Grants Policy Statement.
Applications must be submitted electronically following the instructions described in the SF424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit How to Apply Application Guide. If you encounter a system issue beyond your control that threatens your ability to complete the submission process on-time, you must follow the Dealing with System Issues guidance. For assistance with application submission, contact the Application Submission Contacts in Section VII.
Important reminders:
All PD(s)/PI(s) must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH. See Section III of this FOA for information on registration requirements.
The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization's profile in the eRA Commons and for the System for Award Management. Additional information may be found in the SF424 (R&R) Application Guide.
See more tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness and compliance with application instructions by the Center for Scientific Review . Applications that are incomplete or non-compliant will not be reviewed.
In order to expedite review, applicants are requested to notify the NIMH Referral Office by email at email@example.com when the application has been submitted. Please include the FOA number and title, PD/PI name, and title of the application.
Requests of $500,000 or more for direct costs in any year
Applicants requesting $500,000 or more in direct costs in any year (excluding consortium F&A) must contact a Scientific/ Research Contact at least 6 weeks before submitting the application and follow the Policy on the Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs as described in the SF424 (R&R) Application Guide.
Only the review criteria described below will be considered in the review process. Applications submitted to the NIH in support of the NIH mission are evaluated for scientific and technical merit through the NIH peer review system.
For this particular announcement, note the following:
A proposed Clinical Trial application may include study design, methods, and intervention that are not by themselves innovative but address important questions or unmet needs. Additionally, the results of the clinical trial may indicate that further clinical development of the intervention is unwarranted or lead to new avenues of scientific investigation.
Does the project address an important problem or a critical barrier to progress in the field? Is the prior research that serves as the key support for the proposed project rigorous? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Does the project involve in vivo measurements of neural circuits (in humans and/or animals) or use of existing datasets so obtained? Is the project applying existing or novel XAI techniques to traditional machine learning techniques to provide additional explanatory power to closed-loop neuro-behavioral modulation (e.g., counter-factual probes, generalized additive models, generative adversarial network techniques)? Is the project employing active manipulations (e.g., electric or magnetic brain stimulation, optogenetics, genome editing, pharmacological compounds, or other modalities) of complex neural circuits, especially those involved in mental disorders for model validation? Is the project performing fusion of multimodal behavioral and neurophysiological data?
In addition, for applications involving clinical trials
Are the scientific rationale and need for a clinical trial to test the proposed hypothesis or intervention well supported by preliminary data, clinical and/or preclinical studies, or information in the literature or knowledge of biological mechanisms? For trials focusing on clinical or public health endpoints, is this clinical trial necessary for testing the safety, efficacy or effectiveness of an intervention that could lead to a change in clinical practice, community behaviors or health care policy? For trials focusing on mechanistic, behavioral, physiological, biochemical, or other biomedical endpoints, is this trial needed to advance scientific understanding?
Are the PD(s)/PI(s), collaborators, and other researchers well suited to the project? If Early Stage Investigators or those in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?
Does the research team include experimental and computational domain expertise? Please evaluate the strength of the collaboration between individuals with experimental and computational domain expertise for the proposed project.
In addition, for applications involving clinical trials
With regard to the proposed leadership for the project, do the PD/PI(s) and key personnel have the expertise, experience, and ability to organize, manage and implement the proposed clinical trial and meet milestones and timelines? Do they have appropriate expertise in study coordination, data management and statistics? For a multicenter trial, is the organizational structure appropriate and does the application identify a core of potential center investigators and staffing for a coordinating center?
Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
In addition, for applications involving clinical trials
Does the design/research plan include innovative elements, as appropriate, that enhance its sensitivity, potential for information or potential to advance scientific knowledge or clinical practice?
Does the application contain a novel application of XAI to a neural circuit linked to behavior? Is the XAI model being applied to multi-modal (neural and behavioral) data?
Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Have the investigators included plans to address weaknesses in the rigor of prior research that serves as the key support for the proposed project ? Have the investigators presented strategies to ensure a robust and unbiased approach, as appropriate for the work proposed? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed? Have the investigators presented adequate plans to address relevant biological variables, such as sex, for studies in vertebrate animals or human subjects?
Is the proposed XAI and experimental approach feasible?
If the project involves human subjects and/or NIH-defined clinical research, are the plans to address 1) the protection of human subjects from research risks, and 2) inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion or exclusion of individuals of all ages (including children and older adults), justified in terms of the scientific goals and research strategy proposed?
In addition, for applications involving clinical trials
Does the application adequately address the following, if applicable
Study Design
Is the study design justified and appropriate to address primary and secondary outcome variable(s)/endpoints that will be clear, informative and relevant to the hypothesis being tested? Is the scientific rationale/premise of the study based on previously well-designed preclinical and/or clinical research? Given the methods used to assign participants and deliver interventions, is the study design adequately powered to answer the research question(s), test the proposed hypothesis/hypotheses, and provide interpretable results? Is the trial appropriately designed to conduct the research efficiently? Are the study populations (size, gender, age, demographic group), proposed intervention arms/dose, and duration of the trial, appropriate and well justified?
Are potential ethical issues adequately addressed? Is the process for obtaining informed consent or assent appropriate? Is the eligible population available? Are the plans for recruitment outreach, enrollment, retention, handling dropouts, missed visits, and losses to follow-up appropriate to ensure robust data collection? Are the planned recruitment timelines feasible and is the plan to monitor accrual adequate? Has the need for randomization (or not), masking (if appropriate), controls, and inclusion/exclusion criteria been addressed? Are differences addressed, if applicable, in the intervention effect due to sex/gender and race/ethnicity?
Are the plans to standardize, assure quality of, and monitor adherence to, the trial protocol and data collection or distribution guidelines appropriate? Is there a plan to obtain required study agent(s)? Does the application propose to use existing available resources, as applicable?
Data Management and Statistical Analysis
Are planned analyses and statistical approach appropriate for the proposed study design and methods used to assign participants and deliver interventions? Are the procedures for data management and quality control of data adequate at clinical site(s) or at center laboratories, as applicable? Have the methods for standardization of procedures for data management to assess the effect of the intervention and quality control been addressed? Is there a plan to complete data analysis within the proposed period of the award?
Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
In addition, for applications involving clinical trials
If proposed, are the administrative, data coordinating, enrollment and laboratory/testing centers, appropriate for the trial proposed?
Does the application adequately address the capability and ability to conduct the trial at the proposed site(s) or centers? Are the plans to add or drop enrollment centers, as needed, appropriate?
If international site(s) is/are proposed, does the application adequately address the complexity of executing the clinical trial?
If multi-sites/centers, is there evidence of the ability of the individual site or center to: (1) enroll the proposed numbers; (2) adhere to the protocol; (3) collect and transmit data in an accurate and timely fashion; and, (4) operate within the proposed organizational structure?
Study Timeline
Specific to applications involving clinical trials
Is the study timeline described in detail, taking into account start-up activities, the anticipated rate of enrollment, and planned follow-up assessment? Is the projected timeline feasible and well justified? Does the project incorporate efficiencies and utilize existing resources (e.g., CTSAs, practice-based research networks, electronic medical records, administrative database, or patient registries) to increase the efficiency of participant enrollment and data collection, as appropriate?
Are potential challenges and corresponding solutions discussed (e.g., strategies that can be implemented in the event of enrollment shortfalls)?
For research that involves human subjects but does not involve one of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.
For research that involves human subjects and meets the criteria for one or more of the categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Guidelines for the Review of Human Subjects.
When the proposed project involves human subjects and/or NIH-defined clinical research, the committee will evaluate the proposed plans for the inclusion (or exclusion) of individuals on the basis of sex/gender, race, and ethnicity, as well as the inclusion (or exclusion) of individuals of all ages (including children and older adults) to determine if it is justified in terms of the scientific goals and research strategy proposed. For additional information on review of the Inclusion section, please refer to the Guidelines for the Review of Inclusion in Clinical Research.
The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following criteria: (1) description of proposed procedures involving animals, including species, strains, ages, sex, and total number to be used; (2) justifications for the use of animals versus alternative models and for the appropriateness of the species proposed; (3) interventions to minimize discomfort, distress, pain and injury; and (4) justification for euthanasia method if NOT consistent with the AVMA Guidelines for the Euthanasia of Animals. Reviewers will assess the use of chimpanzees as they would any other application proposing the use of vertebrate animals. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.
Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.
For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.
Not Applicable
Not Applicable
Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: (1) Data Sharing Plan; (2) Sharing Model Organisms; and (3) Genomic Data Sharing Plan (GDS).
For projects involving key biological and/or chemical resources, reviewers will comment on the brief plans proposed for identifying and ensuring the validity of those resources.
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by Center for Scientific Review, in accordance with NIH peer review policy and procedures, using the stated review criteria. Assignment to a Scientific Review Group will be shown in the eRA Commons.
Information regarding the disposition of applications is available in the NIH Grants Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee's business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to terms and conditions found on the Award Conditions and Information for NIH Grants website. This includes any recent legislation and policy applicable to awards that is highlighted on this website.
Individual awards are based on the application submitted to, and as approved by, the NIH and are subject to the IC-specific terms and conditions identified in the NoA.
ClinicalTrials.gov: If an award provides for one or more clinical trials. By law (Title VIII, Section 801 of Public Law 110-85), the "responsible party" must register and submit results information for certain applicable clinical trials on the ClinicalTrials.gov Protocol Registration and Results System Information Website (https://register.clinicaltrials.gov). NIH expects registration and results reporting of all trials whether required under the law or not. For more information, see https://grants.nih.gov/policy/clinical-trials/reporting/index.htm
Institutional Review Board or Independent Ethics Committee Approval: Grantee institutions must ensure that the application as well as all protocols are reviewed by their IRB or IEC. To help ensure the safety of participants enrolled in NIH-funded studies, the awardee must provide NIH copies of documents related to all major changes in the status of ongoing protocols. Data and Safety
Monitoring Requirements: The NIH policy for data and safety monitoring requires oversight and monitoring of all NIH-conducted or -supported human biomedical and behavioral intervention studies (clinical trials) to ensure the safety of participants and the validity and integrity of the data. Further information concerning these requirements is found at http://grants.nih.gov/grants/policy/hs/data_safety.htm and in the application instructions (SF424 (R&R) and PHS 398).
Investigational New Drug or Investigational Device Exemption Requirements: Consistent with federal regulations, clinical research projects involving the use of investigational therapeutics, vaccines, or other medical interventions (including licensed products and devices for a purpose other than that for which they were licensed) in humans under a research protocol must be performed under a Food and Drug Administration (FDA) investigational new drug (IND) or investigational device exemption (IDE).
Recipients of federal financial assistance (FFA) from HHS must administer their programs in compliance with federal civil rights law. This means that recipients of HHS funds must ensure equal access to their programs without regard to a person's race, color, national origin, disability, age and, in some circumstances, sex and religion. This includes ensuring your programs are accessible to persons with limited English proficiency. HHS recognizes that research projects are often limited in scope for many reasons that are nondiscriminatory, such as the principal investigator's scientific interest, funding limitations, recruitment requirements, and other considerations. Thus, criteria in research protocols that target or exclude certain populations are warranted where nondiscriminatory justifications establish that such criteria are appropriate with respect to the health or safety of the subjects, the scientific study design, or the purpose of the research.
In accordance with the statutory provisions contained in Section 872 of the Duncan Hunter National Defense Authorization Act of Fiscal Year 2009 (Public Law 110-417), NIH awards will be subject to the Federal Awardee Performance and Integrity Information System (FAPIIS) requirements. FAPIIS requires Federal award making officials to review and consider information about an applicant in the designated integrity and performance system (currently FAPIIS) prior to making an award. An applicant, at its option, may review information in the designated integrity and performance systems accessible through FAPIIS and comment on any information about itself that a Federal agency previously entered and is currently in FAPIIS. The Federal awarding agency will consider any comments by the applicant, in addition to other information in FAPIIS, in making a judgement about the applicant's integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 45 CFR Part 75.205 Federal awarding agency review of risk posed by applicants. This provision will apply to all NIH grants and cooperative agreements except fellowships.
For additional guidance regarding how the provisions apply to NIH grant programs, please contact the Scientific/Research Contact that is identified in Section VII under Agency Contacts of this FOA. HHS provides general guidance to recipients of FFA on meeting their legal obligation to take reasonable steps to provide meaningful access to their programs by persons with limited English proficiency. Please see https://www.hhs.gov/civil-rights/for-individuals/special-topics/limited-english-proficiency/index.html. The HHS Office for Civil Rights also provides guidance on complying with civil rights laws enforced by HHS. Please see https://www.hhs.gov/civil-rights/for-individuals/section-1557/index.htmlhttps://www.hhs.gov/civil-rights/for-providers/laws-regulations-guidance/index.html. Recipients of FFA also have specific legal obligations for serving qualified individuals with disabilities. Please see https://www.hhs.gov/civil-rights/for-individuals/disability/index.html. Please contact the HHS Office for Civil Rights for more information about obligations and prohibitions under federal civil rights laws at https://www.hhs.gov/ocr/about-us/contact-us/index.html or call 1-800-368-1019 or TDD 1-800-537-7697. Also note it is an HHS Departmental goal to ensure access to quality, culturally competent care, including long-term services and supports, for vulnerable populations. For further guidance on providing culturally and linguistically appropriate services, recipients should review the National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care at http://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=53.
A final RPPR, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
In accordance with the regulatory requirements provided at 45 CFR 75.113 and Appendix XII to 45 CFR Part 75, recipients that have currently active Federal grants, cooperative agreements, and procurement contracts from all Federal awarding agencies with a cumulative total value greater than $10,000,000 for any period of time during the period of performance of a Federal award, must report and maintain the currency of information reported in the System for Award Management (SAM) about civil, criminal, and administrative proceedings in connection with the award or performance of a Federal award that reached final disposition within the most recent five-year period. The recipient must also make semiannual disclosures regarding such proceedings. Proceedings information will be made publicly available in the designated integrity and performance system (currently FAPIIS). This is a statutory requirement under section 872 of Public Law 110-417, as amended (41 U.S.C. 2313). As required by section 3010 of Public Law 111-212, all information posted in the designated integrity and performance system on or after April 15, 2011, except past performance reviews required for Federal procurement contracts, will be publicly available. Full reporting requirements and procedures are found in Appendix XII to 45 CFR Part 75 Award Term and Conditions for Recipient Integrity and Performance Matters.
eRA Service Desk (Questions regarding ASSIST, eRA Commons, application errors and warnings, documenting system problems that threaten submission by the due date, and post-submission issues)
Finding Help Online: http://grants.nih.gov/support/ (preferred method of contact)
Telephone: 301-402-7469 or 866-504-9552 (Toll Free)
General Grants Information (Questions regarding application instructions, application processes, and NIH grant resources)
Email: email@example.com (preferred method of contact)
Telephone: 301-945-7573
Grants.gov Customer Support (Questions regarding Grants.gov registration and Workspace)
Contact Center Telephone: 800-518-4726
Email: email@example.com
Mauricio Rangel-Gomez, Ph.D.
National Institute of Mental Health (NIMH)
Telephone: 301-435-6908
Email: firstname.lastname@example.com
For specific inquiries involving neurostimulation devices in clinical populations contact:
David McMullen, M.D.
National Institute of Mental Health (NIMH)
Telephone: 301-451-0180
Alexei Kondratyev, Ph.D.
Center for Scientific Review (CSR)
Telephone: 301-435-1785
Email:? email@example.com
Terri Jarosik
National Institute of Mental Health (NIMH)
Telephone: 301-443-3858
Email: firstname.lastname@example.com


text:
We never surprise you with unexpected shipping charges, taxes, handling, etc. See our shipping and tax charges policy on our customer service page. All charges are also seen on the order form of our online shopping cart up front before you approve the order.We are not responsible for typographical errors.
© Copyright 2014 PhonesOnSale.com. All Rights Reserved.


text:
elizabethaverylistings.com Privacy Notice for United States and EU Residents
elizabethaverylistings.com. ("elizabethaverylistings.com," "we" or "us") owns, operates, or provides access to elizabethaverylistings.com, email newsletters, and other real estate websites sites, digital platforms and interactive services ("Services"). This Privacy Notice for United States and EU Residents ("Notice") applies only to the Services and does not govern the separate websites, applications, newsletters, platforms and services that elizabethaverylistings.com does not operate or of any third parties that may link to or be linked to from the Services. This Privacy Notice governs our privacy practices in handling the information we collect about individuals in the United States and EU who use our Services ("you" or "your"). Terms that are not defined in this Notice have the same definitions as in elizabethaverylistings.com's Terms of Use. elizabethaverylistings.com processes personal data under this Privacy Notice as a data controller. The Contact Details of elizabethaverylistings.com are listed at the end of this Notice. This Notice may be changed if there is a change in the way elizabethaverylistings.com processes personal data or if there is a change in applicable law. We will notify users of changes that are deemed material under applicable law by updating the date of this Notice and providing other information as required.
Last modified: May 24, 2018.
'Personal data' means any information relating to an identified or identifiable natural person ('data subject'). An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as a name, an identification number, location data, an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person.
Categories of Data Obtained Directly from You
elizabethaverylistings.com obtains personal data from you during signup including your name, email address, property addresses, telephone numbers, and payment card information. We collect name, email and phone number from visitors to the real estate websites you create using our platform if these visitors choose to enter it into our online lead collection forms. We collect this information when you or the visitors to your websites:
Register for an elizabethaverylistings.com account, or subscribe to any elizabethaverylistings.com email newsletter.
Email, text or otherwise share a property from any of the Services.
Contact us for information or ask a question.
Post, upload, or otherwise submit any data from our web forms, or other content ("User Materials") to elizabethaverylistings.com.
If you choose to participate in a survey, we may ask you to provide your date of birth, gender, education level, information about your employment, income level and other information.
Information Obtained Automatically Through Technology
Depending on which Services you use and how you access them, the information collected automatically through technology, such as access logs, cookies, pixels and other tracking technologies, may include:
The Services use third-party analytics, cookie data collection and linking services (collectively "Analytics Services"), including Google Universal Analytics, Google Analytics Demographics and Interest Reporting and DoubleClick for Publishers. These Analytics Services may use cookies, pixel tags, and other tracking and storage technologies to collect or receive information (not including your name or the email address you register with elizabethaverylistings.com) from the Services and elsewhere on the Internet and use that information to analyze and measure elizabethaverylistings.com's audience and target and evaluate the effectiveness of sponsorship credits. For example, elizabethaverylistings.com and Analytics Services may use first-party cookies (such as the Google Analytics cookies) and third-party cookies (such as the DoubleClick cookie) together to inform, optimize, and serve sponsorship messages based on your past interactions with our Services and other websites or services. In addition, we may use analytics data, including but not limited to, geographic, demographic, and interest reporting information to recognize and understand user preferences, make improvements, and for other operational purposes.
Purposes for Processing of Personal Data
elizabethaverylistings.com processes your data in order to:
Manage, administer, promote, analyze and improve the Services and our communications, including measuring and analyzing user traffic and usage patterns. Respond to your questions or messages and fulfill your requests for services. Customize the content you see and hear on our Services.
Process applications for jobs, internships, fellowships and other positions at elizabethaverylistings.com. Manage contests, contact you for an online survey, or for editorial purposes. Recognize you as a returning user as you access our Services using different computers, devices and browsers and to save and "remember" your registration information, settings and preferences for later visits. Send you email newsletters and marketing, membership and other communications from elizabethaverylistings.com. To understand whether and when you read our email messages and click on links in those messages. Analyze personal preferences or interests to provide personalized content and messages from elizabethaverylistings.com and elizabethaverylistings.com sponsors and to control the sequence and frequency of those messages. Generate aggregate or other information that does not directly identify you as an individual or the devices you use to access our Services, and use and share that information for elizabethaverylistings.com's purposes. To prevent potentially prohibited or illegal activities, comply with applicable laws, and enforce our Terms of Use and other legal rights. We also may use the information collected from you in other ways, and for other purposes, that are described to you at the point of collection or for which we otherwise have obtained your consent.
Sharing Your Personal Data
elizabethaverylistings.com may share your personal data with the following categories of recipients:elizabethaverylistings.com's authorized service providers to provide services on our behalf. elizabethaverylistings.com's authorized third-party applications to provide certain Services to you on the third-party applications. elizabethaverylistings.com's analytics partners such as Google Universal Analytics, Google Analytics Demographics and Interest Reporting, DoubleClick for Publishers and others. If we sell a Service or in the unlikely event of bankruptcy.
With public authorities when required by law, to respond to subpoenas, court orders, legal process, and other law enforcement measures, and to comply with legal or regulatory obligations. With other parties when necessary to enforce our Terms of Use, to protect the vital interests of our users or other natural persons, elizabethaverylistings.com, Member stations, and their sponsors, or when required by law. With social networking services, if you choose to share stories or other content with your friends and followers on the social networking service. With other parties if the information is anonymous and aggregate. With other parties if we have disclosed such sharing to you at the time of collection of the information or if we otherwise have your consent. Lawful Basis for the Processing of Personal Data.
elizabethaverylistings.com is required to demonstrate a lawful basis for the processing of personal data. elizabethaverylistings.com relies on legitimate interest to process data for the following purposes:
Your personal data is retained no longer than is reasonably necessary to perform the processing described in this Notice and in case of any legal claims or complaints, or as required by law.
Your Rights
Subject to exemptions under applicable law (which may include, depending on the circumstances, U.S. law protecting the rights to free speech and free press or EU law protecting the rights to freedom of expression or information, including processing for journalistic purposes), you have the following rights with respect to your personal data:
To request a copy of your personal data which elizabethaverylistings.com holds; To request that elizabethaverylistings.com provide you access to and/or rectify personal data that is inaccurate or out of date; To request erasure of your personal data where it is no longer necessary for elizabethaverylistings.com to retain it; If you have consented to processing, the right to withdraw consent at any time; To request that the data controller provide you with your personal data and where possible, to transmit that data directly to another data controller, where applicable. This right of portability only applies where the processing is based on consent or is necessary for the performance of a contract and if elizabethaverylistings.com processes the data by automated means; To request a restriction on further processing where applicable; The right to object to processing if the processing is based on legitimate interest, is for direct marketing, or is for scientific/historical research and statistics; To lodge a complaint with a supervisory authority. You may exercise these rights by contacting elizabethaverylistings.com at firstname.lastname@example.com, providing the email address you used to register with elizabethaverylistings.com, and stating your specific request in writing. elizabethaverylistings.com reserves the right to verify your identity and confirm your right to the information. The following options are also available:
To withdraw consent for collection of precise device location, you may access the privacy settings of your mobile device and/or the settings of the elizabethaverylistings.com mobile application. To withdraw consent to marketing emails or email newsletters, click the "unsubscribe" link on the email. You may also change your newsletter preferences by signing into your account or by contacting us. However, even if you opt out of receiving such communications, we retain the right to send you non-marketing communications (such as information about changes to our Terms of Use or this Notice). To cancel your elizabethaverylistings.com account, or correct or update your registration information, you may sign in to your account or contact us using the information below. To prevent your data from being used by Google Analytics, click here for the Google Universal Analytics opt-out browser add-on: https://tools.google.com/dlpage/gaoptout. To learn more about how Google uses data, visit google.com/policies/privacy/partners/.
Transfer of Data Abroad
If you reside outside the US: elizabethaverylistings.com operates the Services from the US, your personal data may be transferred to the US and/or to countries or territories outside the EEA or Switzerland not recognized by the European Commission as ensuring an adequate level of protection pursuant to the GDPR. Where required, data transfers will be made subject to the terms of the applicable EU Standard Contractual Clauses or with your consent. elizabethaverylistings.com will take all steps reasonably necessary to ensure that personal data is treated securely and in accordance with this Privacy Notice in respect of such transfer.
elizabethaverylistings.com employs physical, technical and organizational safeguards to ensure an appropriate level of security for personal data, taking into account the state of the art, the costs of implementation and the nature, scope, context and purposes of processing as well as the risk of varying likelihood and security for the rights and freedoms of natural persons,
Automated Decision Making and Analysis
elizabethaverylistings.com and its data analytics and sponsorship vendors analyze user interactions with the Services to deliver personalized content to users and to serve personalized sponsorship messages. This includes tracking user preferences with respect to listening data, websites visited, Member station chosen, and search terms in order to derive a user's interests and preferences. The consequences of such processing for the data subject are that the data subject receives content that may be of interest to him or her, as well as email, online and in-app messages from elizabethaverylistings.com and elizabethaverylistings.com's sponsors that are geared towards the interests and preferences of the data subject.
Age Limits
You must be at least 18 years of age to submit any User Materials or Personal Data on or through the Services, create a public profile, or participate in any online contests. If your child is under age 16 and has provided personal data to the Services, please contact us at firstname.lastname@example.com for deletion of the data.
Further Processing
If elizabethaverylistings.com plans to use personal data for a new purpose, it will update this Notice and communicate the changes to individuals before starting any new processing.
Statement Regarding Cookies and Other Tracking Technologies
We and our service providers use cookies to collect information. A cookie is a string of characters that can be written to a file on the user's computer or device when the user visits a site, application, platform or service.
We use the following types of cookies for the purposes set out below:
Essential Cookies
These cookies are essential to provide you with services available through the elizabethaverylistings.com Services and to enable you to use some of their features. For example, these cookies allow elizabethaverylistings.com to remember your registration information while you are logged in and other interactive features also use cookies. Without these cookies, the services that you have asked for cannot be provided, and we only use these cookies to provide you with those services.
Functionality Cookies
These cookies allow our Services to remember choices you make when you use them, such as remembering your Member preferences and remembering your account details. The purpose of these cookies is to provide you with a more personal experience and to avoid you having to re-enter your preferences every time you visit the elizabethaverylistings.com Services.
Analytics and Performance Cookies
These cookies are used to collect information about traffic to our Services and how users interact with the elizabethaverylistings.com Services. The information collected includes the number of visitors to the elizabethaverylistings.com Services, the websites that referred visitors to the elizabethaverylistings.com Services, the pages that they visited on the elizabethaverylistings.com Services, what time of day they visited the elizabethaverylistings.com Services, whether they have visited the elizabethaverylistings.com Services before, and other similar information. We use this information to help operate the elizabethaverylistings.com Services more efficiently, to gather broad demographic information and to monitor the level of activity on the elizabethaverylistings.com Services.
Targeted and Sponsor Cookies
These cookies track your browsing habits or other information, such as location, to enable us to show sponsorship credits which are more likely to be of interest to you. These cookies use information about your browsing history to group you with other users who have similar interests. Based on that information, and with our permission, sponsors can place cookies to enable them to show sponsorship credits and other messages that we think will be relevant to your interests while you are using third-party services.
Social Networking Service Cookies
These cookies are used when you share information using a social media sharing button or you link your account or engage with our content on or through a social networking service such as Facebook, Twitter or Google+. The social networking service will record that you have done this.
Third-Party Cookies
Third-party service providers that measure and analyze the use of the elizabethaverylistings.com Services for elizabethaverylistings.com and serve sponsorship credits and other messages onto the elizabethaverylistings.com Services also use their own cookies. For example, elizabethaverylistings.com's third-party analytics service providers use cookies across multiple sites to collect visitor data (such as data related to age, gender and visitor interests). In addition, elizabethaverylistings.com works with third-party service providers that may serve sponsorship credits or other messages to you on other websites after you visit the elizabethaverylistings.com Services. These third-party service providers use their own cookies to recognize you as an elizabethaverylistings.com Services visitor and to serve you sponsorship credits or other messages on other websites that they believe you will find most relevant. This Privacy Policy does not cover the cookies used by these third-party service providers.
Additionally, we use these technologies:
Pixel tags
elizabethaverylistings.com and its service providers also may use pixel tags, alone or in conjunction with cookies. A pixel tag, also known as a web beacon or clear GIF, is an electronic image that can be used to recognize certain information on your device, such as cookies, the time and date a web page is viewed, or a description of where API content is placed. Cookies and these other tracking technologies enable us to assign a unique number to a user's device, and relate information about a user's use of the elizabethaverylistings.com Services to other information about the user, including personal information. These technologies also enable elizabethaverylistings.com and its service providers to recognize you when you access the elizabethaverylistings.com Services using different computers, devices or browsers.
Flash technology
We also may use Flash cookies (which are also known as Flash LSOs) on the elizabethaverylistings.com Services to collect and store information about your use of the elizabethaverylistings.com Services. Unlike other cookies, Flash cookies cannot be removed or rejected via your browser settings. If you do not want Flash cookies stored on your device, you can adjust the settings of your Flash player to block Flash LSO storage using the tools contained in the Website Storage Settings Panel. You can also control Flash LSOs by going to the Global Storage Settings Panel and following the instructions. Please note that setting the Flash Player to restrict or limit acceptance of Flash LSOs may reduce or impede the functionality of some Flash applications, including, potentially, Flash applications used in connection with certain of the elizabethaverylistings.com Services.
Contact Details
Web Accessibility
elizabethaverylistings.com is committed to making websites built by our platform accessible to all users, including those with disabilities. Our goal is to provide an accessible website that conforms to Section 508 Guidelines and the World Wide Web Consortium's Accessibility Guidelines (WCAG). Some existing content may not be in compliance, and some content may meet only the minimum required compliance standards. elizabethaverylistings.com customers must notify us of any accessibility issues they discover on their existing websites and continue efforts to monitor and notify us of any unacceptable compliance levels. While every effort will be made, it is understood that creating accessible formats for some website content and graphical renderings maintained by elizabethaverylistings.com may be technologically unfeasible, impractical, or creates an undue hardship to elizabethaverylistings.com's operations.
We continue to make every effort to test the websites created by the elizabethaverylistings.com platform and to remove barriers that prevent persons with disabilities from interacting with or accessing information made available on our websites. If we become aware of content that does not conform to the WCAG standards, we will make reasonable good faith efforts to make the content conform to the standards. elizabethaverylistings.com customers must let us know if they encounter difficulty with 3rd party sites we link to so we can pass the information along to the owners of those websites. elizabethaverylistings.com customers should also contact owners of any 3rd party websites to address concerns directly to these third parties.
While this policy does provide the standard for individuals with disabilities to access Web-based information, this policy cannot anticipate every accessibility need, due to known limitations of existing technology. There may be other circumstances, independent of technology that may limit the accessibility of elizabethaverylistings.com's websites.
Adobe Acrobat is required to view and print PDF documents that appear on elizabethaverylistings.com websites. Download the latest free version of Adobe Reader in order to improve the viewing of these files. elizabethaverylistings.com customers must notify us if they believe any PDF content does not meet web accessibility standards.
While we strive to adhere to the accepted guidelines and standards for accessibility and usability, it is not always possible to do so in all areas of the website, particularly as it relates to content by third parties. elizabethaverylistings.com are not responsible for ensuring that third-party content, software/tools, widgets, Add-ins, APIs, etc., which are not owned by elizabethaverylistings.com but are otherwise located on or linked to elizabethaverylistings.com and any websites created by the elizabethaverylistings.com platform, conform to WCAG, and shall not be liable if they are inaccessible to individuals with disabilities.


text:
GIANT SPLIT DRESS, Love, Women
Women's oversize designed college dress, small pockets on the front side. Feels super comfortable to wear! Oversize, normal fit from the sleeves. Over knee length. The Giant Split Dress is a loved Papu classic item and a great choice for every occasion from work to play!
The pattern LOVE tells a story about love that is multi-colored, variegated and can hold even shades of longing. The pattern is casually painted with acrylic paints with darker and lighter areas while orange splashes are used as an accent among the gentle colors. The adjustment of the print may vary between individual items, which may affect the appearance and colors of the item.
Take a look into a measurement table to see the directional measurements of this item.
- Made from organic cotton
- Sizes XXS - XXL
- The model is 178 cm tall and wears a size S
- The model's measurements are bust 88 cm, waist 66 cm and hips 91 cm
Designed with love in Finland. Made with care in Portugal.
College - 95% cotton (organic) / 5% elastane.
Love - Multicolor
Not sure about the right size? Check out our size guide.
Note! To show some true love to your wonderful garment, check and follow the care instructions carefully.
Shipping and delivery
Delivery time
4-5 business days in Finland, 4-7 business days worldwide, when products are in stock. Shipping delays due to the carrier, weekends and holidays may affect delivery time. Orders from papudesign.com are delivered by Posti (Finland) to your closest pick-up location or directly to your home (home delivery) and DHL Express (rest of the world).
The home delivery option in Finland delivers the package directly to your home during the next working day after the order is dispatched from our warehouse. If it cannot be delivered (if no one is there to receive the package) the package will be delivered to the nearest pick up point. Remember to always fill in your phone number correctly to receive shipping updates!
Shipping costs
Shipping costs include the cost of shipping & packaging.
Destination | Shipping cost |
Finland / Standard | 4,90€ |
Finland / Home delivery | 9,90€ |
Europe | 13,90€ |
United Kingdom* | 13,90€ |
Other countries | 29,90€ |
*If you are shopping from the United Kingdom & other countries outside the European Union fiscal area: Papu Design is not responsible for possible customs expenses or other fees that may occur.
You can find the current United Kingdom tax and customs information here: https://www.gov.uk/goods-sent-from-abroad
Shipment tracking
Once your order has been shipped, you will receive an email with a tracking code for your package. You can check the shipping status of your package.


text:
Most of the people at school have stopped making fun of my outfits (with the exception of the Fairy Talely-Challenged child mentioned above) because they feel threatened. Not by me of course-my strength is about that of the hair on the chipmunk inside my mouth-but by the fact that carpet netting, coathangers, and combat boots could all easily injure someone if the wearer were to decide injury was necessary. Which it won't be, unless you give me 10 bucks and a free slice of pizza. Say cheese!I talk way too much. Thank you Yokoo!
blouse and cape, yokoo. mom's old skirt. h&m tights. slow & steady wins the race shoes.


text:
A beautifully mellow smoke grey chunky cardigan that is comfortable chic and warm, It layers beautifully and provides with a plush warm feeling.
COMPOSITION - 100% Cashmere
FEATURES - Hand wash cold or dry clean.
Do not twist or wring.
Reshape and lay flat to dry.
Warm iron if needed
Wool Cashmere
Prices include door delivery to your destination. Available to a select list of countries.
We like to keep it simple without any surprises!
Ever been disappointed by exorbitant shipping costs when shopping online?
At Pashma, we live by transparency and seek to bring simplicity to online shopping.
That is why we offer complimentary international shipping for all orders to a wide range of countries.
Countries eligible for free, all-inclusive shipping
Middle East: UAE, Saudi Arabia, Kuwait, Bahrain, Qatar, Oman.
South and Southeast Asia: India, Sri Lanka, Bangladesh, Singapore, Thailand, Vietnam, Malaysia.
North Asia: Hong Kong, Macau, South Korea, Japan
Europe: Turkey, Eurozone countries, UK, Norway, and Scandinavia
North America: USA, Canada
Oceania: Australia, New Zealand
All purchases are refundable and exchangeable within 20 days of purchase.
The products should come back intact with its original label and tags.
Returns and exchange goods must be in original condition and shipped with packaging to the following.
Address- Revenue Estate, Vill. Narhera Pataudi - Bilaspur Road, Distt. Gurgaon (HR) - 122503
Phone no. - 0124-2672531, 2672541
We accept mail-in returns through the shipping carrier of your choice, and you are responsible for payment to the carrier of your choice.
Prior to initiating a return, please contact us to confirm the refund and shipping instructions.
Thanks for subscribing!
This email has been registered!
Hey there! Love getting the scoop on the latest and greatest?
Join our family and be the first to know about exciting New Arrivals,
The Pashma Indulgence and Exclusive Members only Offers.
Plus, score a sweet 10% OFF your entire purchase as a welcome gift!


text: Items that are in an unwashed, unaltered and unworn condition, returns will be accepted if the items are returned within 7 days of receipt (for both local and international orders). Shipping cost for the return will be borne by the customer. However, customers are advised to notify us at firstname.lastname@example.com by quoting the order number and the product details. Sale items and purchases made with discount coupons are non-returnable. Accessories including jewellery, bags, scarves and hair accessories are non-returnable too. If the item does not fit, you can always email us to exchange the item to another size, subject to our stock availability.


text: This calculator shows rentals that fit your budget. Savings, debt and other expenses could impact the amount you want to spend on rent each month. Input your net (after tax) income and the calculator will display rentals up to 40% of your estimated gross income. Property managers typically use gross income to qualify applicants, so the tool assumes your net income is taxed at 25%. Actual tax rates vary.